泌尿器科領域におけるRiripenの使用経験について
スポンサーリンク
概要
- 論文の詳細を見る
1) A total of 31 patients, mainly composed of urological post-operative cases, was treated with "Riripen" combined with either sulfa drug or antibiotics. The effective rate of the therapy was 83 %. 2) The antifebrile effect of the drug was so marked that almost all patients became afebrile within 2 to 4 days following the administration of the drug. 3) The antalgic and the local anti-inflammatory effects of the drug were also conspicuons, especially for the pain following operations on the scrotum and penis. 4) Side effects were observed in 7 out of 31 cases treated. Slight gastrointestinal disturbances were seen in 6 patients and insomnia due to central nervous disturbance was seen in 1 patient, but such side effects did not necessitate discontinuation of the drug administration.
- 泌尿器科紀要刊行会の論文
泌尿器科紀要刊行会 | 論文
- MVAC療法後の転移性尿路上皮癌に対するGemcitabine, Docetaxel, Carboplatin併用化学療法の検討
- Grade 3 Ta-1表在性膀胱癌に対する膀胱温存治療
- 腹腔鏡下に摘出した後腹膜神経線維腫の1例
- 移植腎生検による腎内動脈瘤破裂の1例
- Modified M-VAC療法後に残存腫瘍切除を施行した進行尿路上皮癌患者の治療成績